ResearcherCity of HopeNo recent work listed

Benjamin L. Johnson

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper

Papers 2

5-Azacytidine Potentiates Anti-tumor Immunity in a Model of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fimmu.2020.00538 ↗
Desmoplasia and oncogene driven acinar-to-ductal metaplasia are concurrent events during acinar cell-derived pancreatic cancer initiation in young adult mice. Co-author DOI 10.1371/journal.pone.0221810 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Don J. Diamond · 2 shared papers, 2019–2020 · strength 0.25
- Paper 5-Azacytidine Potentiates Anti-tumor Immunity in a Model of Pancreatic Ductal Adenocarcinoma. DOI 10.3389/fimmu.2020.00538 ↗
- Paper Desmoplasia and oncogene driven acinar-to-ductal metaplasia are concurrent events during acinar cell-derived pancreatic… DOI 10.1371/journal.pone.0221810 ↗
Edwin Ramos Manuel · 2 shared papers, 2019–2020 · strength 0.25
- Paper 5-Azacytidine Potentiates Anti-tumor Immunity in a Model of Pancreatic Ductal Adenocarcinoma. DOI 10.3389/fimmu.2020.00538 ↗
- Paper Desmoplasia and oncogene driven acinar-to-ductal metaplasia are concurrent events during acinar cell-derived pancreatic… DOI 10.1371/journal.pone.0221810 ↗
Nancy D. Ebelt · 1 shared paper, 2020 · strength 0.15
- Paper 5-Azacytidine Potentiates Anti-tumor Immunity in a Model of Pancreatic Ductal Adenocarcinoma. DOI 10.3389/fimmu.2020.00538 ↗
Marcela d'Alincourt Salazar · 1 shared paper, 2019 · strength 0.11
- Paper Desmoplasia and oncogene driven acinar-to-ductal metaplasia are concurrent events during acinar cell-derived pancreatic… DOI 10.1371/journal.pone.0221810 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.